Agenus Inc Stock Probability Of Bankruptcy

AGEN Stock  USD 3.16  0.16  4.82%   
Agenus' chance of distress is above 80% at this time. It has very high odds of going through financial hardship in the upcoming years. Odds of distress shows the probability of financial torment over the next two years of operations under current economic and market conditions. All items used in analyzing the odds of distress are taken from the Agenus balance sheet, as well as cash flow and income statements available from the company's most recent filings. Check out Agenus Piotroski F Score and Agenus Altman Z Score analysis.
  
As of the 24th of February 2025, Market Cap is likely to drop to about 805.3 M. In addition to that, Enterprise Value is likely to drop to about 550 M

Agenus Inc Company odds of distress Analysis

Agenus' Probability Of Bankruptcy is a relative measure of the likelihood of financial distress. For stocks, the Probability Of Bankruptcy is the normalized value of Z-Score. For funds and ETFs, it is derived from a multi-factor model developed by Macroaxis. The score is used to predict the probability of a firm or a fund experiencing financial distress within the next 24 months. Unlike Z-Score, Probability Of Bankruptcy is the value between 0 and 100, indicating the firm's actual probability it will be financially distressed in the next 2 fiscal years.

Probability Of Bankruptcy

 = 

Normalized

Z-Score

More About Probability Of Bankruptcy | All Equity Analysis

Current Agenus Probability Of Bankruptcy

    
  Over 84%  
Most of Agenus' fundamental indicators, such as Probability Of Bankruptcy, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Agenus Inc is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Our calculation of Agenus probability of bankruptcy is based on Altman Z-Score and Piotroski F-Score, but not limited to these measures. To be applied to a broader range of industries and markets, we use several other techniques to enhance the accuracy of predicting Agenus odds of financial distress. These include financial statement analysis, different types of price predictions, earning estimates, analysis consensus, and basic intrinsic valuation. Please use the options below to get a better understanding of different measures that drive the calculation of Agenus Inc financial health.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Agenus. If investors know Agenus will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Agenus listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(11.02)
Revenue Per Share
7.808
Quarterly Revenue Growth
0.033
Return On Assets
(0.22)
Return On Equity
(12.79)
The market value of Agenus Inc is measured differently than its book value, which is the value of Agenus that is recorded on the company's balance sheet. Investors also form their own opinion of Agenus' value that differs from its market value or its book value, called intrinsic value, which is Agenus' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Agenus' market value can be influenced by many factors that don't directly affect Agenus' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Agenus' value and its price as these two are different measures arrived at by different means. Investors typically determine if Agenus is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Agenus' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Agenus Probability Of Bankruptcy Driver Correlations

Understanding the fundamental principles of building solid financial models for Agenus is extremely important. It helps to project a fair market value of Agenus Stock properly, considering its historical fundamentals such as Probability Of Bankruptcy. Since Agenus' main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Agenus' historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Agenus' interrelated accounts and indicators.
-0.210.17-0.830.80.870.850.52-0.21-0.110.520.720.30.050.870.120.53-0.120.87-0.17-0.44-0.120.77
-0.21-0.440.65-0.47-0.670.11-0.420.310.22-0.47-0.470.59-0.06-0.41-0.310.080.26-0.470.020.910.61-0.37
0.17-0.44-0.40.670.38-0.330.9-0.10.040.820.09-0.43-0.020.54-0.490.510.010.290.08-0.35-0.90.53
-0.830.65-0.4-0.85-0.95-0.53-0.630.490.18-0.62-0.760.09-0.04-0.86-0.1-0.40.24-0.910.110.740.43-0.81
0.8-0.470.67-0.850.860.380.9-0.16-0.30.820.49-0.14-0.180.97-0.150.7-0.320.81-0.2-0.62-0.630.91
0.87-0.670.38-0.950.860.570.63-0.31-0.20.660.78-0.080.070.880.230.38-0.220.89-0.14-0.8-0.430.77
0.850.11-0.33-0.530.380.570.04-0.150.020.10.630.560.150.50.290.230.030.66-0.14-0.130.370.45
0.52-0.420.9-0.630.90.630.04-0.09-0.20.90.26-0.27-0.160.8-0.380.68-0.220.57-0.1-0.49-0.810.78
-0.210.31-0.10.49-0.16-0.31-0.15-0.09-0.21-0.15-0.4-0.07-0.23-0.130.17-0.01-0.04-0.25-0.050.190.05-0.12
-0.110.220.040.18-0.3-0.20.02-0.2-0.21-0.070.210.280.83-0.29-0.18-0.250.97-0.220.570.430.15-0.34
0.52-0.470.82-0.620.820.660.10.9-0.15-0.070.39-0.14-0.080.72-0.150.67-0.090.54-0.24-0.56-0.80.68
0.72-0.470.09-0.760.490.780.630.26-0.40.210.390.270.510.540.250.050.20.710.07-0.55-0.150.44
0.30.59-0.430.09-0.14-0.080.56-0.27-0.070.28-0.140.270.21-0.070.00.170.30.02-0.170.360.39-0.08
0.05-0.06-0.02-0.04-0.180.070.15-0.16-0.230.83-0.080.510.21-0.160.06-0.390.83-0.030.730.10.15-0.28
0.87-0.410.54-0.860.970.880.50.8-0.13-0.290.720.54-0.07-0.16-0.060.68-0.30.86-0.19-0.57-0.510.91
0.12-0.31-0.49-0.1-0.150.230.29-0.380.17-0.18-0.150.250.00.06-0.06-0.26-0.120.13-0.04-0.370.24-0.11
0.530.080.51-0.40.70.380.230.68-0.01-0.250.670.050.17-0.390.68-0.26-0.270.45-0.26-0.09-0.460.68
-0.120.260.010.24-0.32-0.220.03-0.22-0.040.97-0.090.20.30.83-0.3-0.12-0.27-0.230.570.430.17-0.35
0.87-0.470.29-0.910.810.890.660.57-0.25-0.220.540.710.02-0.030.860.130.45-0.23-0.13-0.61-0.320.91
-0.170.020.080.11-0.2-0.14-0.14-0.1-0.050.57-0.240.07-0.170.73-0.19-0.04-0.260.57-0.130.280.13-0.22
-0.440.91-0.350.74-0.62-0.8-0.13-0.490.190.43-0.56-0.550.360.1-0.57-0.37-0.090.43-0.610.280.59-0.52
-0.120.61-0.90.43-0.63-0.430.37-0.810.050.15-0.8-0.150.390.15-0.510.24-0.460.17-0.320.130.59-0.52
0.77-0.370.53-0.810.910.770.450.78-0.12-0.340.680.44-0.08-0.280.91-0.110.68-0.350.91-0.22-0.52-0.52
Click cells to compare fundamentals
The Probability of Bankruptcy SHOULD NOT be confused with the actual chance of a company to file for chapter 7, 11, 12, or 13 bankruptcy protection. Macroaxis simply defines Financial Distress as an operational condition where a company is having difficulty meeting its current financial obligations towards its creditors or delivering on the expectations of its investors. Macroaxis derives these conditions daily from both public financial statements as well as analysis of stock prices reacting to market conditions or economic downturns, including short-term and long-term historical volatility. Other factors taken into account include analysis of liquidity, revenue patterns, R&D expenses, and commitments, as well as public headlines and social sentiment.
Competition

Based on the latest financial disclosure, Agenus Inc has a Probability Of Bankruptcy of 84%. This is 94.04% higher than that of the Biotechnology sector and 53.17% higher than that of the Health Care industry. The probability of bankruptcy for all United States stocks is 110.9% lower than that of the firm.

Agenus Probability Of Bankruptcy Peer Comparison

Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Agenus' direct or indirect competition against its Probability Of Bankruptcy to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Agenus could also be used in its relative valuation, which is a method of valuing Agenus by comparing valuation metrics of similar companies.
84.0073.00100.00100.00100%
Agenus is currently under evaluation in probability of bankruptcy category among its peers.

Agenus Main Bankruptcy Drivers

202020212022202320242025 (projected)
Return On Assets(1.12)(0.2)(0.66)(0.78)(0.9)(0.95)
Asset Turnover0.410.630.240.50.450.47
Gross Profit Margin(0.64)0.38(1.01)(0.52)(0.6)(0.63)
Net Debt(44.1M)(233.6M)(100.2M)274.1M315.3M331.0M
Total Current Liabilities129.9M156.9M189.0M255.9M294.3M309.0M
Non Current Liabilities Total296.1M261.1M279.5M206.4M237.4M249.2M
Total Assets214.5M466.0M413.6M313.9M361.0M379.0M
Total Current Assets113.8M332.0M213.1M112.4M129.3M91.0M
Total Cash From Operating Activities(139.1M)10.1M(175.4M)(224.2M)(201.8M)(191.7M)

Agenus ESG Sustainability

Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, Agenus' sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to Agenus' managers, analysts, and investors.
39.5%
Environmental
67.6%
Governance
74.0%
Social

Agenus Fundamentals

Return On Equity-12.79
JavaScript chart by amCharts 3.21.152011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-31-2,000%-1,500%-1,000%-500%0%500%
Return On Asset-0.22
Profit Margin(1.42) %
JavaScript chart by amCharts 3.21.152011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-31-100%-80%-60%-40%-20%
Operating Margin(1.33) %
JavaScript chart by amCharts 3.21.152011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-31-100%-80%-60%-40%-20%
Current Valuation112.23 M
JavaScript chart by amCharts 3.21.152011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-31-100%-80%-60%-40%-20%
Shares Outstanding23.61 M
JavaScript chart by amCharts 3.21.152011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312,000%4,000%6,000%8,000%10,000%12,000%14,000%
Shares Owned By Insiders1.37 %
Shares Owned By Institutions36.51 %
Number Of Shares Shorted2.93 M
Price To Earning10.52 X
Price To Book218.61 X
JavaScript chart by amCharts 3.21.152011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-31-120%-100%-80%-60%-40%-20%
Price To Sales0.49 X
JavaScript chart by amCharts 3.21.152011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-31-100%-80%-60%-40%-20%
Revenue156.31 M
JavaScript chart by amCharts 3.21.152011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-3150,000%100,000%150,000%200,000%250,000%300,000%
Gross Profit(28.68 M)
JavaScript chart by amCharts 3.21.152011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-31-100,000%-50,000%0%50,000%100,000%
EBITDA(145.92 M)
JavaScript chart by amCharts 3.21.152011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-31-400%-200%0%200%400%600%800%
Net Income(245.76 M)
JavaScript chart by amCharts 3.21.152011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-310%500%1,000%1,500%
Cash And Equivalents218.23 M
Cash Per Share0.72 X
JavaScript chart by amCharts 3.21.152011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-31-100%-50%0%50%100%150%200%250%
Total Debt350.25 M
JavaScript chart by amCharts 3.21.152011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312,000%4,000%6,000%8,000%10,000%12,000%14,000%
Debt To Equity5.88 %
JavaScript chart by amCharts 3.21.152011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-31-4,000%-2,000%0%2,000%
Current Ratio1.45 X
JavaScript chart by amCharts 3.21.152011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-31-80%-60%-40%-20%
Book Value Per Share(13.48) X
JavaScript chart by amCharts 3.21.152011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-31-300%-250%-200%-150%-100%-50%0%
Cash Flow From Operations(224.2 M)
JavaScript chart by amCharts 3.21.152011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-310%500%1,000%1,500%
Short Ratio6.97 X
Earnings Per Share(11.02) X
Target Price8.0
Number Of Employees389
Beta1.3
Market Capitalization78.39 M
JavaScript chart by amCharts 3.21.152011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-31-80%-60%-40%-20%
Total Asset313.91 M
JavaScript chart by amCharts 3.21.152011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-310%200%400%600%
Retained Earnings(1.96 B)
JavaScript chart by amCharts 3.21.152011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-311,000%2,000%3,000%4,000%5,000%
Working Capital(143.48 M)
JavaScript chart by amCharts 3.21.152011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-31
Current Asset63.4 M
JavaScript chart by amCharts 3.21.152011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-310%100%200%300%400%500%600%
Current Liabilities9.97 M
JavaScript chart by amCharts 3.21.152011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312,000%4,000%6,000%8,000%10,000%12,000%14,000%
Net Asset313.91 M

About Agenus Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze Agenus Inc's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Agenus using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Agenus Inc based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
When determining whether Agenus Inc offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Agenus' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Agenus Inc Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Agenus Inc Stock:
Check out Agenus Piotroski F Score and Agenus Altman Z Score analysis.
You can also try the Portfolio Optimization module to compute new portfolio that will generate highest expected return given your specified tolerance for risk.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Agenus. If investors know Agenus will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Agenus listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(11.02)
Revenue Per Share
7.808
Quarterly Revenue Growth
0.033
Return On Assets
(0.22)
Return On Equity
(12.79)
The market value of Agenus Inc is measured differently than its book value, which is the value of Agenus that is recorded on the company's balance sheet. Investors also form their own opinion of Agenus' value that differs from its market value or its book value, called intrinsic value, which is Agenus' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Agenus' market value can be influenced by many factors that don't directly affect Agenus' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Agenus' value and its price as these two are different measures arrived at by different means. Investors typically determine if Agenus is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Agenus' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.